Skip to Content

NeoGenomics Inc NEO

Morningstar Rating
$13.42 −0.11 (0.81%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NEO is trading at a 29% discount.
Price
$13.47
Fair Value
$55.54
Uncertainty
Very High
1-Star Price
$35.77
5-Star Price
$27.81
Economic Moat
Hzwy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NEO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$13.53
Day Range
$13.3413.68
52-Week Range
$11.0321.22
Bid/Ask
$12.57 / $14.60
Market Cap
$1.71 Bil
Volume/Avg
801,900 / 896,928

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.92
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Core
Total Number of Employees
2,100

Comparables

Valuation

Metric
NEO
TIHE
300289
Price/Earnings (Normalized)
207.50
Price/Book Value
1.861.30
Price/Sales
2.924.60
Price/Cash Flow
73.4117.49
Price/Earnings
NEO
TIHE
300289

Financial Strength

Metric
NEO
TIHE
300289
Quick Ratio
5.67
Current Ratio
6.20
Interest Coverage
−15.50
Quick Ratio
NEO
TIHE
300289

Profitability

Metric
NEO
TIHE
300289
Return on Assets (Normalized)
−0.87%
Return on Equity (Normalized)
−1.54%
Return on Invested Capital (Normalized)
−1.52%
Return on Assets
NEO
TIHE
300289
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncCfpnxjpfHmv$206.7 Bil
DHR
Danaher CorpXmchyfcyTrxnxj$175.0 Bil
IQV
IQVIA Holdings IncDxjdxtcfYjjgkp$41.3 Bil
IDXX
IDEXX Laboratories IncGnpfktvzcQnjjsz$39.6 Bil
A
Agilent Technologies IncSzkqbrltgMndy$38.8 Bil
MTD
Mettler-Toledo International IncHhxgjhldPrtjg$25.5 Bil
ICLR
Icon PLCWdrlxrjqDvsnzdv$23.8 Bil
ILMN
Illumina IncMpbhfgbcsKrcdbl$18.6 Bil
WAT
Waters CorpVxkgrszmpYfzl$18.0 Bil
LH
Laboratory Corp of America HoldingsPcpfylfgPzzxgy$16.8 Bil

Sponsor Center